Quyyumi Farah F, Wright Jason D, Accordino Melissa K, Buono Donna, Law Cynthia W, Hillyer Grace C, Neugut Alfred I, Hershman Dawn L
a Department of Medicine, Columbia University College of Physicians and Surgeons , New York , New York , USA.
b Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons , New York , New York , USA.
Cancer Invest. 2019;37(6):233-241. doi: 10.1080/07357907.2019.1624766. Epub 2019 Jul 11.
Multidisciplinary care (MDC) encourages multiple specialists to formulate a unified treatment plan. We sought to determine the frequency and predictors of MDC and assess the association between MDC and nationally-recognized quality metrics in patients with breast cancer. We used the surveillance, epidemiology, and end results-medicare dataset to evaluate patients diagnosed with stages I-III breast cancer who underwent breast-conserving surgery between 2002 and 2011 with follow-up to 2012. We defined MDC as a visit claim from a surgeon, radiation oncologist and medical oncologist within 12 months of diagnosis. We used multivariable regression analysis to determine the association between demographic and clinical variables and MDC, and to assess the association between MDC and three nationally-recognized quality indicators (adjuvant hormone therapy for hormone receptor-positive tumors, chemotherapy for hormone receptor-negative cancer, and radiation after lumpectomy). Of the 61,039 patients in our initial cohort, 53,849 (88.2%) saw a medical oncologist, 46,521 (76.2%) saw a radiation oncologist, and 43,280 (70.9%) were evaluated by all three providers the first year after diagnosis. MDC use was higher in patients with the highest socioeconomic status compared with the lowest [odds ratio (OR) 1.74, 95% CI 1.63-1.86], in patients diagnosed in later years, and those with stage III disease compared to stage I [OR 1.29, 95% CI 1.19-1.41]. Patients older in age (≥80 vs. 65-69 years, OR 0.33, 95% CI 0.31-0.34), patients with more comorbidities, those who lived in a rural setting compared to urban (OR 0.61, 95% CI 0.57-0.64), and unmarried patients (OR 0.79, 95% CI 0.76-0.82) were less likely to see all three providers. In a multivariable analysis, MDC use was associated with increased likelihood of meeting each quality metric. Early stage breast cancer patients were evaluated by a surgeon, radiation oncologist and medical oncologist less than 75% of the time. Enhanced coordination of care and navigation programs may improve the quality of care delivered.
多学科护理(MDC)鼓励多名专家制定统一的治疗方案。我们试图确定MDC的频率和预测因素,并评估MDC与乳腺癌患者全国公认的质量指标之间的关联。我们使用监测、流行病学和最终结果-医疗保险数据集,对2002年至2011年间接受保乳手术且随访至2012年的I-III期乳腺癌确诊患者进行评估。我们将MDC定义为在诊断后12个月内由外科医生、放射肿瘤学家和医学肿瘤学家进行的就诊索赔。我们使用多变量回归分析来确定人口统计学和临床变量与MDC之间的关联,并评估MDC与三个全国公认的质量指标(激素受体阳性肿瘤的辅助激素治疗、激素受体阴性癌症的化疗以及乳房肿瘤切除术后的放疗)之间的关联。在我们最初的队列中的61039名患者中,53849名(88.2%)看过医学肿瘤学家,46521名(76.2%)看过放射肿瘤学家,43280名(70.9%)在诊断后的第一年接受了所有三位医生的评估。社会经济地位最高的患者与最低的患者相比,MDC的使用率更高[优势比(OR)1.74,95%置信区间1.63-1.86],在较晚年份诊断的患者以及III期疾病患者与I期患者相比[OR 1.29,95%置信区间1.19-1.41]。年龄较大(≥80岁与65-69岁相比,OR 0.33,95%置信区间0.31-0.34)、合并症更多、与城市患者相比居住在农村地区的患者(OR 0.61,95%置信区间0.57-0.64)以及未婚患者(OR 0.79,95%置信区间0.76-0.8)见到所有三位医生的可能性较小。在多变量分析中,MDC的使用与达到每个质量指标的可能性增加相关。早期乳腺癌患者接受外科医生、放射肿瘤学家和医学肿瘤学家评估的时间不到75%。加强护理协调和导航计划可能会提高提供的护理质量。